Hosted on MSN2h
Blockbuster weight-loss drugs linked to lower risk of addiction, schizophrenia, dementia, and moreBlockbuster weight loss drugs can help treat ailments as disparate as addiction, blood clotting, and dementia – but they also ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Women's Health on MSN10d
Taking This Weight-Loss Medication Could Slash Dementia Risk, New Research SuggestsResearch shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes ... your risk of ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Blockbuster weight loss drugs can help treat ailments as disparate as addiction, blood clotting, and dementia – but they also come with risks that might give some patients pause, a landmark new ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
The Conversation on MSN8d
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risksResearch shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback